Insulin-exacerbated hypertension in captopril-treated spontaneously hypertensive rats

Role of sympathoexcitation

Sanya Roysommuti, Mahmood S Mozaffari, J. Micheal Wyss

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Insulin excess exacerbates hypertension in spontaneously hypertensive rats (SHR). This study examined the relative contribution of the renin-angiotensin system and the sympathetic nervous system in this phenomenon. In SHR, daily subcutaneous injections of insulin were initiated either before short-term angiotensin-converting enzyme inhibition with captopril or after lifetime captopril treatment. Insulin treatment resulted in significant increases in mean arterial pressure and heart rate and captopril treatment lowered arterial pressure, but captopril did not lower arterial pressure more in the insulin-treated compared with control rats. To test the contribution of the sympathetic nervous system to this form of hypertension, each rat was intravenously infused with either a ganglionic blocker (i.e., hexamethonium) or a centrally acting α 2 -adrenergic receptor agonist (i.e., clonidine). Administration of either agent largely eliminated the differences in mean arterial pressure and heart rate between the insulin-treated and saline-treated SHR, irrespective of captopril treatment. These data indicate that in SHR, the ability of insulin to increase blood pressure is closely related to sympathoexcitation, which is unresponsive to blockade of angiotensin-converting enzyme.

Original languageEnglish (US)
Pages (from-to)1036-1041
Number of pages6
JournalCanadian Journal of Physiology and Pharmacology
Volume81
Issue number11
DOIs
StatePublished - Nov 1 2003

Fingerprint

Captopril
Inbred SHR Rats
Insulin
Hypertension
Arterial Pressure
Sympathetic Nervous System
Peptidyl-Dipeptidase A
Heart Rate
Ganglionic Blockers
Hexamethonium
Adrenergic Agonists
Clonidine
Subcutaneous Injections
Therapeutics
Renin-Angiotensin System
Blood Pressure

Keywords

  • Blood pressure
  • Captorpil
  • Clonidine
  • Hexamethonium
  • Insulin
  • Rat

ASJC Scopus subject areas

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Insulin-exacerbated hypertension in captopril-treated spontaneously hypertensive rats : Role of sympathoexcitation. / Roysommuti, Sanya; Mozaffari, Mahmood S; Wyss, J. Micheal.

In: Canadian Journal of Physiology and Pharmacology, Vol. 81, No. 11, 01.11.2003, p. 1036-1041.

Research output: Contribution to journalArticle

@article{e515c1e8c33c4b13959f80a64d904796,
title = "Insulin-exacerbated hypertension in captopril-treated spontaneously hypertensive rats: Role of sympathoexcitation",
abstract = "Insulin excess exacerbates hypertension in spontaneously hypertensive rats (SHR). This study examined the relative contribution of the renin-angiotensin system and the sympathetic nervous system in this phenomenon. In SHR, daily subcutaneous injections of insulin were initiated either before short-term angiotensin-converting enzyme inhibition with captopril or after lifetime captopril treatment. Insulin treatment resulted in significant increases in mean arterial pressure and heart rate and captopril treatment lowered arterial pressure, but captopril did not lower arterial pressure more in the insulin-treated compared with control rats. To test the contribution of the sympathetic nervous system to this form of hypertension, each rat was intravenously infused with either a ganglionic blocker (i.e., hexamethonium) or a centrally acting α 2 -adrenergic receptor agonist (i.e., clonidine). Administration of either agent largely eliminated the differences in mean arterial pressure and heart rate between the insulin-treated and saline-treated SHR, irrespective of captopril treatment. These data indicate that in SHR, the ability of insulin to increase blood pressure is closely related to sympathoexcitation, which is unresponsive to blockade of angiotensin-converting enzyme.",
keywords = "Blood pressure, Captorpil, Clonidine, Hexamethonium, Insulin, Rat",
author = "Sanya Roysommuti and Mozaffari, {Mahmood S} and Wyss, {J. Micheal}",
year = "2003",
month = "11",
day = "1",
doi = "10.1139/y03-095",
language = "English (US)",
volume = "81",
pages = "1036--1041",
journal = "Canadian Journal of Physiology and Pharmacology",
issn = "0008-4212",
publisher = "National Research Council of Canada",
number = "11",

}

TY - JOUR

T1 - Insulin-exacerbated hypertension in captopril-treated spontaneously hypertensive rats

T2 - Role of sympathoexcitation

AU - Roysommuti, Sanya

AU - Mozaffari, Mahmood S

AU - Wyss, J. Micheal

PY - 2003/11/1

Y1 - 2003/11/1

N2 - Insulin excess exacerbates hypertension in spontaneously hypertensive rats (SHR). This study examined the relative contribution of the renin-angiotensin system and the sympathetic nervous system in this phenomenon. In SHR, daily subcutaneous injections of insulin were initiated either before short-term angiotensin-converting enzyme inhibition with captopril or after lifetime captopril treatment. Insulin treatment resulted in significant increases in mean arterial pressure and heart rate and captopril treatment lowered arterial pressure, but captopril did not lower arterial pressure more in the insulin-treated compared with control rats. To test the contribution of the sympathetic nervous system to this form of hypertension, each rat was intravenously infused with either a ganglionic blocker (i.e., hexamethonium) or a centrally acting α 2 -adrenergic receptor agonist (i.e., clonidine). Administration of either agent largely eliminated the differences in mean arterial pressure and heart rate between the insulin-treated and saline-treated SHR, irrespective of captopril treatment. These data indicate that in SHR, the ability of insulin to increase blood pressure is closely related to sympathoexcitation, which is unresponsive to blockade of angiotensin-converting enzyme.

AB - Insulin excess exacerbates hypertension in spontaneously hypertensive rats (SHR). This study examined the relative contribution of the renin-angiotensin system and the sympathetic nervous system in this phenomenon. In SHR, daily subcutaneous injections of insulin were initiated either before short-term angiotensin-converting enzyme inhibition with captopril or after lifetime captopril treatment. Insulin treatment resulted in significant increases in mean arterial pressure and heart rate and captopril treatment lowered arterial pressure, but captopril did not lower arterial pressure more in the insulin-treated compared with control rats. To test the contribution of the sympathetic nervous system to this form of hypertension, each rat was intravenously infused with either a ganglionic blocker (i.e., hexamethonium) or a centrally acting α 2 -adrenergic receptor agonist (i.e., clonidine). Administration of either agent largely eliminated the differences in mean arterial pressure and heart rate between the insulin-treated and saline-treated SHR, irrespective of captopril treatment. These data indicate that in SHR, the ability of insulin to increase blood pressure is closely related to sympathoexcitation, which is unresponsive to blockade of angiotensin-converting enzyme.

KW - Blood pressure

KW - Captorpil

KW - Clonidine

KW - Hexamethonium

KW - Insulin

KW - Rat

UR - http://www.scopus.com/inward/record.url?scp=0347360101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347360101&partnerID=8YFLogxK

U2 - 10.1139/y03-095

DO - 10.1139/y03-095

M3 - Article

VL - 81

SP - 1036

EP - 1041

JO - Canadian Journal of Physiology and Pharmacology

JF - Canadian Journal of Physiology and Pharmacology

SN - 0008-4212

IS - 11

ER -